Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide

To evaluate the toxicity and efficacy of chemoradiotherapy with temozolomide (TMZ) administered in an intensified 1-week on/1-week off schedule plus indomethacin in patients with newly diagnosed glioblastoma.

Saved in:

Bibliographic Details
Main Authors:	Weiler, Markus (Author) , Hartmann, Christian (Author) , Wiewrodt, Dorothee (Author) , Herrlinger, Ulrich (Author) , Gorlia, Thierry (Author) , Bähr, Oliver (Author) , Meyermann, Richard (Author) , Bamberg, Michael (Author) , Tatagiba, Marcos (Author) , Deimling, Andreas von (Author) , Weller, Michael (Author) , Wick, Wolfgang (Author)
Format:	Article (Journal)
Language:	English
Published:	2010
In:	International journal of radiation oncology, biology, physics Year: 2010, Volume: 77, Issue: 3, Pages: 670-676
ISSN:	1879-355X
DOI:	10.1016/j.ijrobp.2009.05.031
Online Access:	Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ijrobp.2009.05.031 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0360301609007949
Author Notes:	Markus Weiler, Christian Hartmann, Dorothee Wiewrodt, Ulrich Herrlinger, Thierry Gorlia, Oliver Bähr, Richard Meyermann, Michael Bamberg, Marcos Tatagiba, Andreas von Deimling, Michael Weller, and Wolfgang Wick

Description
Summary:	To evaluate the toxicity and efficacy of chemoradiotherapy with temozolomide (TMZ) administered in an intensified 1-week on/1-week off schedule plus indomethacin in patients with newly diagnosed glioblastoma.
Item Description:	Online veröffentlicht am 14. Oktober 2009 Gesehen am 19.10.2023
Physical Description:	Online Resource
ISSN:	1879-355X
DOI:	10.1016/j.ijrobp.2009.05.031